4.6 Review

The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions

Journal

PHARMACEUTICALS
Volume 14, Issue 4, Pages -

Publisher

MDPI
DOI: 10.3390/ph14040293

Keywords

Neuropeptide S (NPS); NPS receptor (NPSR); central nervous system; food intake; anorexigenic peptide; CRF; Orexin-A; gastrointestinal function; eating behavior; stress

Funding

  1. Italian Ministry of Education, University and Research [PRIN2015KP7T2Y]

Ask authors/readers for more resources

Neuropeptide S (NPS) acts as the endogenous ligand of the NPS receptor (NPSR) and plays a role in various brain functions, including promoting locomotor activity, behavioral arousal, and anxiolytic effects. Additionally, the NPS system is implicated in drug reward properties and food intake regulation, showing anorexigenic effects and potential for developing novel pharmacological tools for treating aberrant feeding patterns and obesity.
The Neuropeptide S (NPS), a 20 amino acids peptide, is recognized as the endogenous ligand of a previously orphan G protein-coupled receptor, now termed NPS receptor (NPSR). The limited distribution of the NPS-expressing neurons in few regions of the brainstem is in contrast with the extensive expression of NPSR in the rodent central nervous system, suggesting the involvement of this receptor in several brain functions. In particular, NPS promotes locomotor activity, behavioral arousal, wakefulness, and unexpectedly, at the same time, it exerts anxiolytic-like properties. Intriguingly, the NPS system is implicated in the rewarding properties of drugs of abuse and in the regulation of food intake. Here, we focus on the anorexigenic effect of NPS, centrally injected in different brain areas, in both sated and fasted animals, fed with standard or palatable food, and, in addition, on its influence in the gastrointestinal tract. Further investigations, regarding the role of the NPS/NPSR system and its potential interaction with other neurotransmitters could be useful to understand the mechanisms underlying its action and to develop novel pharmacological tools for the treatment of aberrant feeding patterns and obesity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available